LFVN Lifevantage Corp

  1. Stocks
  2. Consumer Defensive
  3. NASDAQ: LFVN

Price (delayed)

$6.62

Market cap

$83.52M

P/E Ratio

14.39

Dividend/share

$0.19

EPS

$0.46

Enterprise value

$81.24M

?
Relative Growth: Rel. Growth: 38
Relative Strength: Rel. Strength: 46
Relative Valuation: Rel. Valuation: 83
Relative Profitability: Rel. Profitability: 66

LifeVantage Corporation is a pioneer in Nutrigenomics - a new science dedicated to biohacking the human aging code. The Company engages in the identification, research, development and distribution of advanced ...

Highlights
The debt has contracted by 17% YoY and by 4.5% from the previous quarter
The price to earnings (P/E) is 32% less than the 5-year quarterly average of 21.3 but 22% more than the last 4 quarters average of 11.8
LFVN's quick ratio is up by 14% since the previous quarter but it is down by 6% year-on-year
LFVN's EPS is down by 39% YoY and by 27% QoQ
The net income has contracted by 37% YoY and by 27% from the previous quarter
Sector: Consumer Defensive
Industry: Packaged Foods
Website: http://www.lifevantage.com/
Peers: NATR OGEN USNA MTEX

Key stats

What are the main financial stats of LFVN

LFVN stock price

How has the Lifevantage stock price performed over time
Intraday
-0.45%
1 week
3.28%
1 month
-4.47%
1 year
-48.4%
YTD
7.47%
QTD
53.24%

Financial performance

How have Lifevantage's revenue and profit performed over time
Revenue
$195.32M
Gross profit
$152.62M
Operating income
$6.58M
Net income
$5.75M
Gross margin
78.1%
Net margin
2.9%
LFVN's operating income is down by 49% year-on-year and by 27% since the previous quarter
The company's operating margin fell by 41% YoY and by 21% QoQ
The net income has contracted by 37% YoY and by 27% from the previous quarter
The net margin has contracted by 29% YoY and by 22% from the previous quarter

Price vs fundamentals

How does LFVN's price correlate with its fundamentals

Growth

What is Lifevantage's growth rate over time

Valuation

What is Lifevantage stock price valuation
LFVN P/E details
P/E
14.39
P/B
2.54
P/S
0.43
EV/EBIT
12.01
EV/EBITDA
7.38
EV/Sales
0.42
LFVN's EPS is down by 39% YoY and by 27% QoQ
The price to earnings (P/E) is 32% less than the 5-year quarterly average of 21.3 but 22% more than the last 4 quarters average of 11.8
The price to book (P/B) is 18% lower than the last 4 quarters average of 3.1 and 15% lower than the 5-year quarterly average of 3.0
The P/S is 14% less than the last 4 quarters average of 0.5 but 8% more than the 5-year quarterly average of 0.4
The revenue has declined by 12% year-on-year and by 7% since the previous quarter

Efficiency

How efficient is Lifevantage business performance
The return on invested capital has dropped by 51% year-on-year and by 28% since the previous quarter
LFVN's return on equity is down by 45% year-on-year and by 26% since the previous quarter
LFVN's ROS is down by 38% YoY and by 20% QoQ
The company's return on assets fell by 34% YoY and by 22% QoQ

Dividends

What is LFVN's dividend history
Dividend details
DPS
$0.19
Dividend yield
2.79%
Payout ratio
40.2%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Lifevantage financials performed over time
Lifevantage's total assets is 116% more than its total liabilities
The company's total liabilities fell by 33% YoY but it rose by 2.2% QoQ
Lifevantage's total assets has decreased by 20% YoY
The debt is 69% less than the equity
The debt has contracted by 17% YoY and by 4.5% from the previous quarter
The company's debt to equity fell by 14% YoY and by 3.1% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.